Perinatal outcome in sickle cell anemia: A prospective study from India

Hemoglobin

Volumn 37, Issue 6, 2013, Pages 507-515

  Daigavane, Mayoor M ^a   Jena, Rabindra K ^a   Kar, Tushar J ^a  

^a Shri Ramachandra Bhanj Medical College   (India)

Author keywords

Arab Asian haplotype; Hydroxyurea (HU); Low birth weight; Preeclempsia; Sickle cell anemia

Indexed keywords

HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA;

ADULT; ANEMIA; ARTICLE; BIRTH WEIGHT; BLOOD TRANSFUSION; CESAREAN SECTION; FEEDING DIFFICULTY; FEMALE; FERRITIN BLOOD LEVEL; FETUS ECHOGRAPHY; FIBRINOGEN BLOOD LEVEL; GENOTYPE; HAPLOTYPE; HIGH RISK PREGNANCY; HUMAN; INDIA; INTRAUTERINE GROWTH RETARDATION; IRON OVERLOAD; IRON THERAPY; JAUNDICE; LIVE BIRTH; LOW BIRTH WEIGHT; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MECONIUM ASPIRATION; NEWBORN; NEWBORN DEATH; PARTIAL THROMBOPLASTIN TIME; PERINATAL ASPHYXIA; PERINATAL DEATH; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURITY; PRIMIGRAVIDA; PROSPECTIVE STUDY; SCREENING TEST; SICKLE CELL ANEMIA; SPONTANEOUS ABORTION; STILLBIRTH;

ADULT; ANEMIA, SICKLE CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; INFANT, NEWBORN; OUTCOME ASSESSMENT (HEALTH CARE); PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84887251350     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2013.828301     Document Type: Article

References (14)

1. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997337(11762-769.
2. Oner C, Dimovski AJ, Olivieri NF, et al. S Haplotypes in various world populations. Hum Genet. 89(1) 99-104.
3. Charache S, Scott J, Niebyl J, Bonds D. Management of sickle disease in pregnant patients. Obstet Gynecol. 1980;55(4):407-410.
4. Seoud MA, Cantwell C, Nobles G, Levy DL. Outcome of pregnancy complicated by sickle cell and sickle-C hemoglobinopathies. Am J Perinatal. 1994;11(3):187-191.
5. Tuck SM, Studd JW, White JM. Pregnancy in women with sickle cell triat. Br J Obstet Gynecol. 1983;90 (2):112-117.
6. Morris CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program. 2008:177-185.
7. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332(20):1317-1322.
8. Morris JS, Dunn DT, Poddar D, Serjeant GR. Hematological risk factor for pregnancy outcome in Jamaica. Br J Obstet Gynecol. 1994;101(9):770-773.
9. Thornburg CD, Files BA, Luo Z, et al.; BABY HUG Investigators. Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood. 2012;120(22):4304-4310.
10. Liebelt EL, Balk SJ, Faber W, et al. NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea. Birth Defects Res B Dev Reprod Toxicol. 2007;80(4):259-366.
11. Ballas SK, McCarthy WF, Gua N, et al. Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia. J Natl Med Assoc. 2009;101(10):1046-1051.
12. Hendrickse JP, Watson-Williams EJ. The influence of hemoglobinopathy on reproduction.AmJ Obstet Gynecol. 1966;94(5):739-748.
13. Ware RE. Vaso-occlusion in sickle cell anemia. Proceedings of the 16th Congress of the European Haematology Association, London, UK, June 9-12 2011. Eur Haematol Assoc. 2011;5:323-329.
14. Rathod KB, Jaiswal KN, Shrivastava AC, Shrikhande AV. Study of placenta in sickle cell disorders. Indian J Pathol Microbial. 2007;50(4):698-701.